RGEN
Repligen Corp
Price:  
155.25 
USD
Volume:  
324,863.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGEN Intrinsic Value

-76.50 %
Upside

As of 2024-12-12, the Intrinsic Value of Repligen Corp (RGEN) is 36.50 USD. This RGEN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 155.25 USD, the upside of Repligen Corp is -76.50%.

The range of the Intrinsic Value is 25.47 - 75.47 USD

155.25 USD
Stock Price
36.50 USD
Intrinsic Value
Intrinsic Value Details

RGEN Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) 25.47 - 75.47 36.50 -76.5%
DCF (Growth 10y) 51.06 - 163.16 75.86 -51.1%
DCF (EBITDA 5y) 69.25 - 82.01 77.55 -50.0%
DCF (EBITDA 10y) 100.08 - 129.32 116.79 -24.8%
Fair Value -6.71 - -6.71 -6.71 -104.32%
P/E (8.17) - 39.30 14.77 -90.5%
EV/EBITDA (18.73) - 54.95 15.36 -90.1%
EPV 31.32 - 40.14 35.73 -77.0%
DDM - Stable (3.09) - (12.83) (7.96) -105.1%
DDM - Multi 36.76 - 118.34 56.08 -63.9%

RGEN Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 8,698.66
Beta 0.48
Outstanding shares (mil) 56.03
Enterprise Value (mil) 8,436.30
Market risk premium 4.60%
Cost of Equity 7.98%
Cost of Debt 5.50%
WACC 7.76%